Home › NDC Lookup › RxCUI directory › RxCUI 1922764

Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet [Betapace] — RxCUI 1922764

RxNorm drug concept · Semantic branded drug
RxCUI 1922764 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1922764
Official nameAtrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet [Betapace]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBetapace AF 160 MG Oral Tablet; Atrial Fibrillation Betapace 160 MG Oral Tablet
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sotalol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a fair question — and I understand it feels like a lot. The reason is that sotalol can actually trigger the very type of dangerous heart rhythm it's supposed to treat, espec...
  • Why do I have to start this medicine in the hospital? Can't I just take it at home?
  • Some things like mild fatigue, a slightly slower heart rate, or feeling a bit lightheaded are common and often settle down. But there are symptoms you should never sit on — if you...
  • What side effects should I just ride out, and which ones mean I need to call for help right away?
📖 Read our full Sotalol guide →

🕸️ Concept Web — How Atrial Fibrillation sotalol hydrochloride 160 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet [Betapace] RxCUI 1922764

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sotalol 9947
    • Sotalol hydrochloride 7008
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Betapace 224909
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sotalol Oral Tablet 373937
    • Sotalol hydrochloride Oral Tablet 2648136
    • Sotalol Oral Product 1161104
    • Sotalol Pill 1161105
    • Sotalol hydrochloride Oral Product 2659339
    • Sotalol hydrochloride Pill 2660941
    • Sotalol Oral Tablet [Betapace] 367639
    • Sotalol hydrochloride Oral Tablet [Betapace] 2657970
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atrial Fibrillation sotalol hydrochloride 160 MG Oral Tablet SCD · 1922763
  • Sotalol hydrochloride 160 MG SCDC · 904578
  • Sotalol Oral Tablet SCDF · 373937
  • Sotalol hydrochloride Oral Tablet SCDFP · 2648136
  • Sotalol Oral Product SCDG · 1161104
  • Sotalol Pill SCDG · 1161105
  • Sotalol hydrochloride Oral Product SCDGP · 2659339
  • Sotalol hydrochloride Pill SCDGP · 2660941

Brand-Name Concepts

  • Sotalol hydrochloride 160 MG [Betapace] SBDC · 904580
  • Sotalol Oral Tablet [Betapace] SBDF · 367639
  • Sotalol hydrochloride Oral Tablet [Betapace] SBDFP · 2657970
  • Betapace Oral Product SBDG · 1172920
  • Betapace Pill SBDG · 1172921
  • Betapace BN · 224909

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 1922764 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83107-0005-10 100 TABLET in 1 BOTTLE (83107-005-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0006-10 100 TABLET in 1 BOTTLE (83107-006-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0007-10 100 TABLET in 1 BOTTLE (83107-007-10) BETAPACE Legacy Pharma USA, Inc. 2016-09-01
83107-0008-60 60 TABLET in 1 BOTTLE (83107-008-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
83107-0009-60 60 TABLET in 1 BOTTLE (83107-009-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
83107-0010-60 60 TABLET in 1 BOTTLE (83107-010-60) BETAPACE AF Legacy Pharma USA, Inc. 2016-09-01
Observed labelers: Legacy Pharma USA, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.